Atopic dermatitis Trials in Huntington Beach, United States
Conditions / Atopic dermatitis / Huntington Beach, United States
Atopic dermatitis is a medical condition with active clinical research programs worldwide.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03817190 | Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis | TERMINATED | PHASE2 |
| NCT07011706 | ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis | RECRUITING | PHASE2 |
| NCT03864627 | A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis | TERMINATED | PHASE2 |
| NCT05142774 | Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT03745651 | TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT03646604 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis | COMPLETED | PHASE1 |
| NCT05995964 | A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis | RECRUITING | PHASE2 |
| NCT04162769 | A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT05032859 | Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) | COMPLETED | PHASE3 |
| NCT03703102 | Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE2 |